Profil
Mr. Neil S.
Belloff was previously employed as a Secretary & General Counsel by Acorda Therapeutics, Inc., a COO, Secretary, EVP & General Counsel by Eloxx Pharmaceuticals, Inc., a Senior Corporate Counsel by Celgene Corp., and an Executive VP, US Corporate & Securities Counsel by Deutsche Telekom AG.
He received his undergraduate degree from Queens College, a graduate degree from New York University and a graduate degree from Quinnipiac University School of Law.
Tidigare kända positioner av Neil Belloff
| Företag | Position | Slut |
|---|---|---|
| ACORDA THERAPEUTICS, INC. | Generell Rådgivare | 2024-08-21 |
| ELOXX PHARMACEUTICALS, INC. | Verksamhetschef | 2021-08-25 |
| CELGENE | Företagsledare/Principal | - |
| DEUTSCHE TELEKOM AG | Företagsledare/Principal | - |
Neil Belloffs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 7 |
|---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Deutsche Telekom AG
Deutsche Telekom AG Major TelecommunicationsCommunications Provides telecommunication services | Communications |
Acorda Therapeutics, Inc.
Acorda Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops neurology therapies | Health Technology |
Queens College
Queens College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University
New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Quinnipiac University School of Law
Quinnipiac University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eloxx Pharmaceuticals, Inc.
Eloxx Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that discovers and develops therapeutics to treat cystic fibrosis, inherited retinal disorders and other diseases | Health Technology |
















